Literature DB >> 34253679

Latent class analysis-derived subphenotypes are generalisable to observational cohorts of acute respiratory distress syndrome: a prospective study.

Pratik Sinha1, Kevin L Delucchi2, Yue Chen3, Hanjing Zhuo4, Jason Abbott4, Chunxue Wang5, Nancy Wickersham5, J Brennan McNeil5, Alejandra Jauregui3, Serena Ke3, Kathryn Vessel3, Antonio Gomez3,6, Carolyn M Hendrickson6, Kirsten N Kangelaris3,7, Aartik Sarma8, Aleksandra Leligdowicz9, Kathleen D Liu4, Michael A Matthay10, Lorraine B Ware11,12, Carolyn S Calfee4,8,10.   

Abstract

RATIONALE: Using latent class analysis (LCA), two subphenotypes of acute respiratory distress syndrome (ARDS) have consistently been identified in five randomised controlled trials (RCTs), with distinct biological characteristics, divergent outcomes and differential treatment responses to randomised interventions. Their existence in unselected populations of ARDS remains unknown. We sought to identify subphenotypes in observational cohorts of ARDS using LCA.
METHODS: LCA was independently applied to patients with ARDS from two prospective observational cohorts of patients admitted to the intensive care unit, derived from the Validating Acute Lung Injury markers for Diagnosis (VALID) (n=624) and Early Assessment of Renal and Lung Injury (EARLI) (n=335) studies. Clinical and biological data were used as class-defining variables. To test for concordance with prior ARDS subphenotypes, the performance metrics of parsimonious classifier models (interleukin 8, bicarbonate, protein C and vasopressor-use), previously developed in RCTs, were evaluated in EARLI and VALID with LCA-derived subphenotypes as the gold-standard.
RESULTS: A 2-class model best fit the population in VALID (p=0.0010) and in EARLI (p<0.0001). Class 2 comprised 27% and 37% of the populations in VALID and EARLI, respectively. Consistent with the previously described 'hyperinflammatory' subphenotype, Class 2 was characterised by higher proinflammatory biomarkers, acidosis and increased shock and worse clinical outcomes. The similarities between these and prior RCT-derived subphenotypes were further substantiated by the performance of the parsimonious classifier models in both cohorts (area under the curves 0.92-0.94). The hyperinflammatory subphenotype was associated with increased prevalence of chronic liver disease and neutropenia and reduced incidence of chronic obstructive pulmonary disease. Measurement of novel biomarkers showed significantly higher levels of matrix metalloproteinase-8 and markers of endothelial injury in the hyperinflammatory subphenotype, whereas, matrix metalloproteinase-9 was significantly lower.
CONCLUSION: Previously described subphenotypes are generalisable to unselected populations of non-trauma ARDS. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  ARDS; critical care; cytokine biology

Mesh:

Substances:

Year:  2021        PMID: 34253679      PMCID: PMC8688287          DOI: 10.1136/thoraxjnl-2021-217158

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  37 in total

1.  Kinetics and Role of Plasma Matrix Metalloproteinase-9 Expression in Acute Lung Injury and the Acute Respiratory Distress Syndrome.

Authors:  Albert T Hsu; Christopher D Barrett; George M DeBusk; Christian D Ellson; Shiva Gautam; Daniel S Talmor; Diana C Gallagher; Michael B Yaffe
Journal:  Shock       Date:  2015-08       Impact factor: 3.454

Review 2.  Organ interactions in the adult respiratory distress syndrome during sepsis. Role of the liver in host defense.

Authors:  G M Matuschak; J E Rinaldo
Journal:  Chest       Date:  1988-08       Impact factor: 9.410

3.  Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury.

Authors:  Lorraine B Ware; Mark D Eisner; B Taylor Thompson; Polly E Parsons; Michael A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2004-06-16       Impact factor: 21.405

4.  Lack of matrix metalloproteinase-9 worsens ventilator-induced lung injury.

Authors:  Guillermo M Albaiceta; Ana Gutiérrez-Fernández; Diego Parra; Aurora Astudillo; Emilio García-Prieto; Francisco Taboada; Antonio Fueyo
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-01-25       Impact factor: 5.464

Review 5.  Influence of Clinical Factors and Exclusion Criteria on Mortality in ARDS Observational Studies and Randomized Controlled Trials.

Authors:  Faye M Pais; Pratik Sinha; Kathleen D Liu; Michael A Matthay
Journal:  Respir Care       Date:  2018-07-10       Impact factor: 2.258

6.  Early elevation of matrix metalloproteinase-8 and -9 in pediatric ARDS is associated with an increased risk of prolonged mechanical ventilation.

Authors:  Michele Y F Kong; Yao Li; Robert Oster; Amit Gaggar; J P Clancy
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

7.  Early Plasma Matrix Metalloproteinase Profiles. A Novel Pathway in Pediatric Acute Respiratory Distress Syndrome.

Authors:  Matt S Zinter; Kevin L Delucchi; Michele Y Kong; Benjamin E Orwoll; Aaron S Spicer; Michelle J Lim; Mustafa F Alkhouli; Anna E Ratiu; Anne V McKenzie; Patrick S McQuillen; Christopher C Dvorak; Carolyn S Calfee; Michael A Matthay; Anil Sapru
Journal:  Am J Respir Crit Care Med       Date:  2019-01-15       Impact factor: 30.528

8.  Neutropenic sepsis is associated with distinct clinical and biological characteristics: a cohort study of severe sepsis.

Authors:  John P Reilly; Brian J Anderson; Kristin M Hudock; Thomas G Dunn; Altaf Kazi; Anna Tommasini; Dudley Charles; Michael G S Shashaty; Mark E Mikkelsen; Jason D Christie; Nuala J Meyer
Journal:  Crit Care       Date:  2016-07-18       Impact factor: 9.097

Review 9.  Acute respiratory distress syndrome.

Authors:  Michael A Matthay; Rachel L Zemans; Guy A Zimmerman; Yaseen M Arabi; Jeremy R Beitler; Alain Mercat; Margaret Herridge; Adrienne G Randolph; Carolyn S Calfee
Journal:  Nat Rev Dis Primers       Date:  2019-03-14       Impact factor: 52.329

10.  Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.

Authors:  Pratik Sinha; Kevin L Delucchi; B Taylor Thompson; Daniel F McAuley; Michael A Matthay; Carolyn S Calfee
Journal:  Intensive Care Med       Date:  2018-10-05       Impact factor: 17.440

View more
  8 in total

Review 1.  Phenotyping in acute respiratory distress syndrome: state of the art and clinical implications.

Authors:  Narges Alipanah; Carolyn S Calfee
Journal:  Curr Opin Crit Care       Date:  2022-02-01       Impact factor: 3.687

2.  BIOMARKERS IN THE ACUTE RESPIRATORY DISTRESS SYNDROME: PAST, PRESENT, AND FUTURE.

Authors:  Polly E Parsons
Journal:  Trans Am Clin Climatol Assoc       Date:  2022

3.  New Insights into Clinical and Mechanistic Heterogeneity of the Acute Respiratory Distress Syndrome: Summary of the Aspen Lung Conference 2021.

Authors:  Thomas R Martin; Rachel L Zemans; Lorraine B Ware; Eric P Schmidt; David W H Riches; Lisa Bastarache; Carolyn S Calfee; Tushar J Desai; Susanne Herold; Catherine L Hough; Mark R Looney; Michael A Matthay; Nuala Meyer; Samir M Parikh; Troy Stevens; B Taylor Thompson
Journal:  Am J Respir Cell Mol Biol       Date:  2022-09       Impact factor: 7.748

4.  Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis.

Authors:  Manoj V Maddali; Matthew Churpek; Tai Pham; Emanuele Rezoagli; Hanjing Zhuo; Wendi Zhao; June He; Kevin L Delucchi; Chunxue Wang; Nancy Wickersham; J Brennan McNeil; Alejandra Jauregui; Serena Ke; Kathryn Vessel; Antonio Gomez; Carolyn M Hendrickson; Kirsten N Kangelaris; Aartik Sarma; Aleksandra Leligdowicz; Kathleen D Liu; Michael A Matthay; Lorraine B Ware; John G Laffey; Giacomo Bellani; Carolyn S Calfee; Pratik Sinha
Journal:  Lancet Respir Med       Date:  2022-01-10       Impact factor: 102.642

5.  Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids.

Authors:  Pratik Sinha; David Furfaro; Matthew J Cummings; Darryl Abrams; Kevin Delucchi; Manoj V Maddali; June He; Alison Thompson; Michael Murn; John Fountain; Amanda Rosen; Shelief Y Robbins-Juarez; Matthew A Adan; Tejus Satish; Mahesh Madhavan; Aakriti Gupta; Alexander K Lyashchenko; Cara Agerstrand; Natalie H Yip; Kristin M Burkart; Jeremy R Beitler; Matthew R Baldwin; Carolyn S Calfee; Daniel Brodie; Max R O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2021-12-01       Impact factor: 21.405

Review 6.  Promises and challenges of personalized medicine to guide ARDS therapy.

Authors:  Katherine D Wick; Daniel F McAuley; Joseph E Levitt; Jeremy R Beitler; Djillali Annane; Elisabeth D Riviello; Carolyn S Calfee; Michael A Matthay
Journal:  Crit Care       Date:  2021-11-23       Impact factor: 19.334

Review 7.  Subphenotypes in acute kidney injury: a narrative review.

Authors:  Suvi T Vaara; Pavan K Bhatraju; Natalja L Stanski; Blaithin A McMahon; Kathleen Liu; Michael Joannidis; Sean M Bagshaw
Journal:  Crit Care       Date:  2022-08-19       Impact factor: 19.334

8.  Differential Protein Expression among Two Different Ovine ARDS Phenotypes-A Preclinical Randomized Study.

Authors:  Karin Wildi; Mahe Bouquet; Carmen Ainola; Samantha Livingstone; Sebastiano Maria Colombo; Silver Heinsar; Noriko Sato; Kei Sato; Emily Wilson; Gabriella Abbate; Margaret R Passmore; Kieran Hyslop; Keibun Liu; Gianluigi Li Bassi; Jacky Y Suen; John F Fraser
Journal:  Metabolites       Date:  2022-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.